ISRAEL’S MEDICAL ACHIEVEMENTS
Brain bleed detection gets Europe approval. Israel’s Zebra Medical Vision has received EU regulatory approval (i.e. the CE mark) for its new algorithm capable of detecting Intracranial hemorrhages (brain bleeds) from uploaded CT or MRI Scans. http://www.calcalistech.com/ctech/articles/0,7340,L-3733482,00.html
Glucose analyzer gets Europe approval. I reported previously (twice) about Israel’s DreaMed Diabetes monitors for analyzing the data from Continuous Glucose Monitors (CGMs). DreaMed has just received the CE mark from the European Union for its Advisor Pro product.
https://www.timesofisrael.com/israeli-smart-software-harnesses-flood-of-data-to-manage-diabetes-care/
https://www.youtube.com/embed/_eMkeq0lrFc?rel=0
Excellent results for new prostate cancer test. (TY Hazel) I reported previously (July 2016) that Israel’s Micromedic Technologies had good results in an 18-patient trial of its CellDetect prostate cancer diagnosis solution. Latest tests on 59 samples were 80% successful – far exceeding the 25% for existing PSI tests.
https://www.israel21c.org/israeli-breakthrough-in-noninvasive-prostate-cancer-test/
Lifestyle controls your microbiome. Scientists at Israel’s Weizmann Institute have found from a study of over 1,000 Israelis that there is no genetic link to the good bacteria in your gut (microbiome). A person’s health (cholesterol, weight, blood glucose levels etc.) however, can be controlled by maintaining a healthy stomach.
https://wis-wander.weizmann.ac.il/life-sciences/genetics-or-lifestyle-what-it-shapes-our-microbiome
A diagnostic kit on a USB drive. The tech-transfer company of Ben-Gurion University, plus Israeli-founded, Singapore-based Biosensorix, are developing $5 disease diagnosis kits that connect to a smartphone via its USB port. Instead of sending samples for lab tests, medical staff can get immediate blood test results and decide on a course of action. https://www.israel21c.org/new-usb-like-diagnostic-kits-provide-faster-results/
Using AI to analyze biopsies. Israeli startup Nucleai is developing computer vision and artificial intelligence (AI) to help overworked pathologists process and analyze biopsies for cancer quicker and more accurately. Nucleai founders have years of experience of computer vision gained during their IDF service.
https://www.timesofisrael.com/israeli-startup-aims-at-disease-diagnosis-helping-pathologists-process-biopsies/
UK-Israel fund to research aging process. The UK has launched a new £5m fund to promote scientific collaboration and research between Israel and the UK into the aging process. The Britain Israel Research and Academic Exchange (BIRAX) Aging fund will also promote research that into aging-related diseases.
https://www.timesofisrael.com/uk-sets-up-5m-fund-for-collaboration-with-israel-on-aging-process/
$20 million donation for nuclear medicine center. Russian Jewish billionaire Roman Abramovich has donated $20 million to Israel’s Sheba Medical Center to build a new medical center for nuclear medicine and research. Its cyclotron particle accelerator will use radioactive ion beams to pinpoint and kill cancer cells.
http://www.jewishpress.com/news/chessed-and-tzedaka/billionaire-donates-20m-to-israels-sheba-hospital-for-nuclear-medicine-research-center/2018/03/03/